Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Alternative and Complementary Medicine (1)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Anatomy (1)
- Animal Structures (1)
- Biochemistry (1)
-
- Biological Factors (1)
- Biology (1)
- Biotechnology (1)
- Cancer Biology (1)
- Cell Anatomy (1)
- Cell Biology (1)
- Cells (1)
- Chemicals and Drugs (1)
- Developmental Biology (1)
- Embryonic Structures (1)
- Medical Education (1)
- Medical Sciences (1)
- Medicine and Health Sciences (1)
- Nucleic Acids, Nucleotides, and Nucleosides (1)
- Other Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Other Biochemistry, Biophysics, and Structural Biology (1)
- Other Cell and Developmental Biology (1)
- Physical Sciences and Mathematics (1)
- Surgical Procedures, Operative (1)
- Therapeutics (1)
Articles 1 - 2 of 2
Full-Text Articles in Molecular Biology
Therapies For Mitochondrial Disorders, Kayli Sousa Smyth, Anne Mulvihill
Therapies For Mitochondrial Disorders, Kayli Sousa Smyth, Anne Mulvihill
SURE Journal: Science Undergraduate Research Experience Journal
Mitochondria are cytoplasmic, double-membrane organelles that synthesise adenosine triphosphate (ATP). Mitochondria contain their own genome, mitochondrial DNA (mtDNA), which is maternally inherited from the oocyte. Mitochondrial proteins are encoded by either nuclear DNA (nDNA) or mtDNA, and both code for proteins forming the mitochondrial oxidative phosphorylation (OXPHOS) complexes of the respiratory chain. These complexes form a chain that allows the passage of electrons down the electron transport chain (ETC) through a proton motive force, creating ATP from adenosine diphosphate (ADP). This study aims to explore current and prospective therapies for mitochondrial disorders (MTDS). MTDS are clinical syndromes coupled with abnormalities …
Immediate-Early Genes And Delayed Primary Response Genes Regulated By Nmu In Skbr3 Her-2 Positive Breast Cancer Cell Line, Jessica Murphy, Sweta Rani
Immediate-Early Genes And Delayed Primary Response Genes Regulated By Nmu In Skbr3 Her-2 Positive Breast Cancer Cell Line, Jessica Murphy, Sweta Rani
SURE Journal: Science Undergraduate Research Experience Journal
Background
Breast cancer is a heterogeneous disease that consists of varying genetic, cellular and molecular subtypes with unique characteristics. Due to the multiple subtypes and molecular markers of breast cancer, successful clinical treatment is hampered by the lack of reliable biomarkers. HER2-positive breast cancer is an aggressive subtype associated with poor patient prognosis. Although survival rates have dramatically increased due to the development of Trastuzumab in 1997, many patients develop a resistance to this therapeutic treatment and relapse over time. Rani et al. (2014), have associated the acquirement of resistance to HER2-treatment with Neuromedin U, but the mechanisms by …